NL-OMON44726已完成不适用
Subcutaneous immunoglobulins with rHuPH20 in multifocal motor neuropathy - Hymne
niversitair Medisch Centrum0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
Trial is onging in other countries
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Fulfilling the EFNS/PNS criteria of propable or definite MMN
- •- Age >= 18 years.
- •- Stable on IVIG maintenance treatment in the year preceding the study.
排除标准
- •- Treatment with other immunosuppressive drugs (cyclophosphamide, azathioprine, cyclosporine) in the 6 months preceding the study.
- •- Female patient who is pregnant or breast-feeding or of childbearing potential.
研究者
相似试验
Unknown
不适用
HyQvia in Multifocal Motor NeuropathyMultifocal Motor NeuropathyNCT02885259UMC Utrecht20
进行中（未招募）
1 期
Immunoglobulins given under the skin to treat patients with multifocal motor neuropathy (MMN). To increase the amount of immunoglobulins, an enzyme is added that will temporarily create more space under the skin. This space is filled with immunoglobulins. By this way less infusions should be needed.EUCTR2015-000828-28-NLMC Utrecht
已完成
2 期
FAST Fish Phase IIb Clinical Trial for the Treatment of Fish Allergy by Subcutaneous ImmunotherapyFood Allergy to FishNCT02382718George Stavroulakis45
已完成
2 期
Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous IgSecondary Immune DeficiencyNCT03211065Rochester General Hospital16
已完成
2 期
Immune Globulin Subcutaenous (Human), 20%Primary Immunodeficiency Diseases (PID)NCT01412385Baxalta now part of Shire55